Mercans Launches G2N Nova: Its Latest Gross-to-Net Multi-country Payroll Engine
Mercans, global payroll technology leader, has introduced its groundbreaking third-generation software, G2N Nova. The latest version of Mercans’ disruptive payroll platform enhances global gross-to-net payroll calculation capabilities and introduces new features that enable multinationals to consolidate and digitalize their international payroll processes.
Mercans' innovative payroll technology challenges the traditional global outsourcing model that is heavily reliant on in-country payroll providers (ICPs) and third-party software solutions. G2N Nova, purpose-built for global payroll, leverages cutting-edge innovations like Machine learning, RPA, Data lakes, Unstructured data management, and digital datafication.
While the traditional legacy payroll software solutions are unable to support multiple countries on a single version, Mercans' horizontal payroll engine architecture reuses the commonalities between payroll calculations across the globe and addresses country-specific regulations through an easily configurable compliance module. This allows G2N Nova to generate statutory-compliant gross-to-net calculations across 100+ countries on a single software instance and in a multi-tenant environment, significantly increasing the accuracy of the tax configurations and payroll calculations.
"Our strategic focus is on SaaS and payroll technology, particularly in the realm of gross-to-net payroll capabilities in a multi-country setting," explains K A Vishwanathan (Vish), CEO of Mercans Payroll & SaaS business.
G2N Nova introduces Complex Event Recognition technology that analyzes data from Human Capital Management (HCM) systems and automatically identifies payroll-relevant events, making the implementation of integrations between G2N Nova and HCM systems more than 5 times faster and reducing the need for any manual intervention by at least 20 times.
"Our objective is to transform the payroll industry from a services-based model to a technology-driven one," affirms Vish. "We envision a fully digital payroll experience that revolutionizes how organizations manage their payroll processes globally. G2N Nova is a significant step towards realizing this vision."
G2N Nova also includes Supernova Payment Gateway module that enables global payroll payments to be routed through any number of financial institutions and payment channels.
Unlike the payment solution offered by other providers, Mercans’ Supernova Payment Gateway does not rely on a single payment channel but routes payments through tens of channels concurrently, creating a virtual payment Super Optimizer. Supernova analyzes each payment instruction, its source and target currencies, initiator and beneficiary, processing fees, and execution time to determine the most optimal routing for each payment instruction. Supernova reduces international banking fees by at least 3 times and the average payment processing time by more than 2 times.
Mercans' Gross to Net Payroll Engine integrates seamlessly with all major HCM systems, providing organizations with a seamless and owned solution for gross-to-net calculations. The addition of an Application Programming Interface (API) specifically for payroll-related data further optimizes the integration process and simplifies payroll processing workflows.
Bottom Line:
The release of G2N Nova marks a significant milestone in Mercans' journey of excellence. Mercans continues to transform the way organizations manage their payroll processes worldwide by combining cutting-edge technology, global best practices, and a customer-centric approach.
Note: The shortened press release highlights key points about G2N Nova and its impact on the global payroll industry. However, for a comprehensive understanding, it's recommended to refer to the original press release for additional details.
About Mercans
Mercans is a global leader in payroll technology. Mercans’ revolutionary global payroll platform HR Blizz enables SMBs & Enterprise businesses to manage payrolls across 160 countries. With 20 years of global payroll expertise, Mercans delivers the full spectrum of HR services through a single, secure global platform.
Visit www.mercans.com
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230725146199/en/
Contact information
Mohsin Khan
hello@mercans.com
Berkeley Square House, 2nd Floor, Berkeley Square, London, UK.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte to Present Multiple Studies from Dermatology Portfolio at 2023 European Academy of Dermatology and Venereology (EADV) Congress29.9.2023 20:43:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced multiple abstracts featuring new data from across its dermatology portfolio have been accepted for presentation at the upcoming European Academy of Dermatology and Venereology (EADV) Congress 2023 held October 11-14 in Berlin. “We are pleased to add to the data supporting the use of ruxolitinib cream for patients living with vitiligo and atopic dermatitis (AD) through two late-breaking presentations – one on prolonged use of treatment in vitiligo patients with limited or no initial response, and the full results of our TRuE-AD3 trial in pediatric AD,” said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation & Autoimmunity, Incyte. “Collectively, the data at this year's Congress, which also include new late-breaking data for povorcitinib in vitiligo, emphasize our ongoing efforts to advance treatment options for the Dermatology community." Key abstracts from Incyte-sponsored programs include: Late-breaking Oral Presentations Vitiligo Efficacy an
Q4 Inc. Recognized as one of Canada’s Top Growing Companies by The Globe and Mail29.9.2023 17:30:00 EEST | Press release
Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), the leading capital markets access platform, is pleased to announce their ranking on the 2023 Report on Business of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Q4 earned its spot with three-year growth of 150%. “We are honored to be recognized as one of Canada’s Top Growing Companies for the fourth consecutive year by The Globe and Mail,” remarked Darrell Heaps, Founder and CEO of Q4. “We are proud of the growth we have achieved as a company and this recognition is a true reflection of our dedication to helping our clients win in the capital markets through innovative technology on the Q4 Platform.” Canada’s Top Growing Companies is an editorial ranking that was launched in 2019. It aims to bring the accomplishments of innovative businesses in Canada to the forefront. In order to qualify for this voluntary program; companies had to complete an in-depth application proc
GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine29.9.2023 16:15:00 EEST | Press release
GEDi Cube Intl Ltd. (GEDi Cube), an AI medical technology company, and Renovaro Biosciences Inc. (NASDAQ:RENB) (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive agreement to combine, in which GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition (the “Transaction”). If completed, the Transaction will result in a combined company that will offer advanced early diagnosis and early identification of recurring cancer as well as potential therapies for several critical diseases such as pancreatic cancer and other solid tumors with poor life expectancy. The combined company will have a unique advantage: Renovaro Biosciences’ pre-clinical and clinical trial data could be utilized to accelerate GEDi Cube’s AI capabilities that, in turn, could potentially help to accelerate Renovaro’s development of potential new therapies. AI will be used to advance the fields of diagnosis and treatment with
Offshore Windfarm Hollandse Kust Zuid Inaugurated29.9.2023 14:53:00 EEST | Press release
Today, Dutch King Willem-Alexander jointly with the board members of Vattenfall, BASF, and Allianz officially inaugurated the offshore wind farm Hollandse Kust Zuid 1-4. The wind farm is in the North Sea, 18-36 kilometers off the Dutch coast between the towns of Scheveningen and Zandvoort. The 139 turbines have a total capacity of 1.5 GW, making it one of the largest offshore wind farms in the world. The annual electricity production is expected to equal the consumption of 1.5 million households. Hollandse Kust Zuid is owned by Vattenfall, BASF, and Allianz. The wind farm is expected to be fully operational in 2024 and will be serviced out of the port of IJmuiden. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230929518869/en/ Inauguration Hollandse Kust Zuid wind farm. From left to right: Helene Biström (Senior Vice President, Head of Business Area Wind Vattenfall), Martijn Hagens (CEO Vattenfall Netherlands), His Majesty K
The Estée Lauder Companies Launches 2023 Breast Cancer Campaign: Beautifully United to Help End Breast Cancer29.9.2023 14:00:00 EEST | Press release
For more than 30 years, The Estée Lauder Companies’ Breast Cancer Campaign (The Campaign) has been dedicated to advancing the possibility of a breast cancer-free world for all. This October, The Estée Lauder Companies (ELC) honors Breast Cancer Awareness Month by launching The Campaign in support of the global breast cancer community. As ELC’s largest corporate social impact program, The Campaign continues to inspire purpose-driven action and is a cornerstone of the company’s social investments in women’s advancement, health and education. Through The Campaign, ELC has also been a longstanding supporter of women in science, research and medicine – funding numerous grants and programs around the world and accelerating opportunities for women in STEM. The Campaign was founded by Evelyn H. Lauder in 1992 with the launch of the iconic Pink Ribbon. At a time when breast cancer wasn’t spoken about openly, Evelyn and ELC saw an opportunity to bring awareness to the disease and address stigmas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom